MENLO PARK, Calif.,
June 7, 2017 /PRNewswire/ --
BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical
company focusing on dermatology, today announced that it will
release its financial results for the fiscal first quarter ended
Apr. 30, 2017 after the close of
trading on Tuesday, Jun. 13, 2017.
The company's management team will host a corresponding conference
call beginning at 1:30 p.m.
PT/4:30 p.m. ET to discuss the
financial results and recent business developments.
Individuals interested in listening to the conference call may
do so by dialing (844) 850-0549 for domestic callers or (412)
317-5206 for international callers, and request to join the
BioPharmX Corporation call. To listen to a live webcast, please
visit the investor relations section of the BioPharmX website at:
www.BioPharmX.com.
A replay of the call will be available beginning Jun. 13 at 3:30 p.m.
PT/6:30 p.m. ET through
midnight ET on Jul. 13, 2017. To access the replay, dial (877)
344-7529 or (412) 317-0088 and reference Conference ID: 10108734.
The webcast will also be available on the BioPharmX website for 90
days following the completion of the call.
About BioPharmX® Corporation
BioPharmX Corporation
(NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical
company, that seeks to provide products through proprietary
platform technologies for prescription, over-the-counter (OTC), and
supplement applications in the health and wellness markets,
including dermatology and women's health. To learn more about
BioPharmX, visit www.BioPharmX.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-to-report-first-quarter-financial-results-300469963.html
SOURCE BioPharmX Corporation